Thorough QT cardiac safety study of pyridoxamine

Trial Profile

Thorough QT cardiac safety study of pyridoxamine

Phase of Trial: Phase I

Latest Information Update: 05 Jan 2015

At a glance

  • Drugs Pyridoxamine (Primary)
  • Indications Diabetic nephropathies
  • Focus Adverse reactions
  • Sponsors NephroGenex
  • Most Recent Events

    • 05 Jan 2015 New trial record
    • 30 Dec 2014 Results published in a NephroGenex media release.
    • 30 Dec 2014 This trial has been completed, according to a NephroGenex media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top